NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older (Q44418730)

2 December 2017

title

NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older (English)

1 reference

2 December 2017

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older (English)

1 reference

Crossref

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

28 December 2023

1 reference

1 reference

coronary artery disease

1 reference

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

28 December 2023

author name string

Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

2 December 2017

National Cholesterol Education Program (NCEP)

1 reference

2 December 2017

Charles M. Alexander

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716754

28 December 2023

Pamela B. Landsman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716754

28 December 2023

Steven M. Teutsch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716754

28 December 2023

Steven M. Haffner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716754

28 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

1 reference

inferred from page(s)

https://diabetesjournals.org/diabetes/article-pdf/52/5/1210/655112/db0503001210.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716754

https://journals.org/diabetes/diabetes/article-pdf/52/5/1210/655112/db0503001210.pdf

28 December 2023

file format

Portable Document Format

1 reference

Crossref

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

https://diabetesjournals.org/diabetes/article-pdf/52/5/1210/655112/db0503001210.pdf

28 December 2023

file format

Portable Document Format

1 reference

Crossref

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

28 December 2023

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

1210-1214

1 reference

Associazione di iperlipemia, diabete mellito e obesita' di medio grado

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Banting lecture 1988. Role of insulin resistance in human disease

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Is glucose a continuous risk factor for cardiovascular mortality?

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Impaired glucose tolerance is it relevant for cardiovascular disease?

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Cardiovascular morbidity and mortality associated with the metabolic syndrome

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Diagnosing insulin resistance in the general population

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

The homeostasis model in the San Antonio Heart Study

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Hyperinsulinemia and atherosclerosis

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

The continuing epidemics of obesity and diabetes in the United States

28 December 2023

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.5.1210

28 December 2023

Identifiers

1 reference

2 December 2017

1 reference